Mental Disorders in Postpartum Period and Lactation: A Literature Review
DOI:
https://doi.org/10.12775/QS.2026.54.70125Keywords
postpartum period, lactation, psychopharmacological treatmentAbstract
Traditionally, postpartum mental problems have been characterized as major depressive disorder, obsessive-compulsive disorder, bipolar disorder, postpartum psychosis, and postpartum blues. The difficult postpartum phase is characterized by major changes in one's physical, biological, social, and emotional makeup. This period necessitates significant interpersonal and personal adjustment, especially for primigravida women. A wide range of emotions are typical during pregnancy and the postpartum phase, ranging from anticipation, fulfillment, and excitement to feelings of anxiety, confusion, frustration, guilt, and sadness. This may cause the mother's psychological condition to deteriorate. Misdiagnosis and inadequate treatment of prenatal mental illnesses are common. Both the mother and the child may have long-term effects from postpartum mental health disorders.The postpartum psychological state might become so severe that hospitalization is required. Furthermore, this conditions might have a negative impact on mother-infant connection and attachment. Early diagnosis and starting the treatment of postpartum psychiatric disorder is important, which can result in faster and quicker recovery. When the disease is mild or in its early stages, non-pharmacological treatment methods like psychotherapy, psychoeducation, and social and familial support might be beneficial. When the condition is more serious, medication is used. However, women should be mindful of the risks and benefits of using psychoactive medications during lactation, even though pharmacological treatment is more effective. Numerous factors, such as the mother's medication dosage, the time and frequency of dosing, the mother's drug metabolism rate, and the infant's drug metabolism, influence how much drug an infant is exposed to.
References
1. Balaram K, Marwaha R. Postpartum Blues. 2022 Mar 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls PMID: 32119433.
2. Berle JO, Spigset O. Antidepressant Use During Breastfeeding. Curr Womens Health Rev. 2011. (1):28-34. doi: 10.2174/157340411794474784. PMID: 22299006; PMCID: PMC3267169.
3. Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L., & Rubinow, D. R. 2000. Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry, 157(6), 924e930. https://doi.org/10.1176/ appi.ajp.157.6.924.
4. Bourin M, Chue P, Guillon Y. 2001. Paroxetine: a review. CNS Drug Rev. Spring;7(1):25-47. doi: 10.1111/j.1527-3458.2001.tb00189.x. PMID: 11420571; PMCID: PMC6741642.
Canadian Mental Health Association (CMHA). 2018. Postpartum Depression. Retrieved from https://cmha.ca/documents/postpartum-depression
5. Carter, C. S. 2014. Oxytocin pathways and the evolution of human behaviour. Annual Review of Psychology, 65, 17e39. https://doi.org/10.1146/annurev-psych-010213- 115110.
Choi Y, Bishai D, Minkovitz CS. 2009. Multiple births are a risk factor for postpartum maternal depressive symptoms. Pediatrics. (4):1147-54. doi: 10.1542/peds.2008-1619. PMID: 19336374.
6. Clark, C. T., & Wisner, K. L. 2018. Treatment of Peripartum Bipolar Disorder. Obstetrics and gynecology clinics of North America, 45(3), 403–417. https://doi.org/10.1016/j.ogc.2018.05.002
7. Costas, J., Gratacos, M., Escaramis, G., Martin-Santos, R., de Diego, Y., Baca-Garcia, E., Sanjuan, J. 2010. Association study of 44 candidate genes with depressive and anxiety symptoms in post-partum women. Journal of Psychiatric Research, 44(11), 717e724. https://doi.org/10.1016/j.jpsychires.2009.12.012.
8. Cuomo A., Maina G., Neal S., De Montis G., Rosso G., Scheggi S.,Beccarini Crescenzi B., Bolognesi S., Goracci A., Coluccia A., Ferretti F. & Fagiolini A. 2018. Using sertraline in postpartum and breastfeeding: balancing risks and benefits, Expert Opinion on Drug Safety, 17:7, 719-725, DOI: 10.1080/14740338.2018.1491546
9. Doornbos, B., Dijck-Brouwer, D. J., Kema, I. P., Tanke, M. A., Van Goor, S. A., Muskiet, F. A., & Korf, J. 2009. The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33(7), 1250-1254. doi:10.1016/j.pnpbp.2009.07.013
10. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD) 2006. National Library of Medicine (US);. Paroxetine. 2022 May 15. PMID: 30000249.
11. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD) 2006. : National Library of Medicine (US); Fluvoxamine. 2022 Apr 18. PMID: 30000246.
12. Dubey, A., Chatterjee, K., Chauhan, V. S., Sharma, R., Dangi, A., & Adhvaryu, A. 2021. Risk factors of postpartum depression. Industrial psychiatry journal, 30(Suppl 1), S127–S131. https://doi.org/10.4103/0972-6748.328803
13. Epperson, C. & Huang, Ming-Yi & Cook, Keziah & Gupta, Deepshekhar & Chawla, Anita & Greenberg, Paul & Eldar-Lissai, Adi. 2020. Healthcare resource utilization and costs associated with postpartum depression among commercially insured households. Current Medical Research and Opinion. 36. 1-1. 10.1080/03007995.2020.1799772.
14. Feldman, R. 2012. Oxytocin and social affiliation in humans. Hormones and Behaviour, 61(3), 380e391.
15. Figueira, P., Malloy-Diniz, L., Campos, S. B., Miranda, D. M., Romano-Silva, M. A., De Marco, L., Correa, H. 2010. An association study between the Val66Met polymorphism of the BDNF gene and postpartum depression. Archives of Women’s Mental Health, 13(3), 285e289.
16. Fitelson E, Kim S, Baker AS, Leight K. 2010. Treatment of postpartum depression: clinical, psychological and pharmacological options. Int J Womens Health. 3:1-14. doi: 10.2147/IJWH.S6938. PMID: 21339932; PMCID: PMC3039003.
17. Frieder, A., Fersh, M., Hainline, R., & Deligiannidis, K. M. 2019. Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development. CNS Drugs. doi:10.1007/s40263-019-00605-7
18. Gehrmann, A., Fiedler, K., Leutritz, A. L., Koreny, C., & Kittel-Schneider, S. 2021. Lithium Medication in Pregnancy and Breastfeeding - A Case Series. Medicina, 57(6), 634. doi:10.3390/medicina57060634
19. Ghaedrahmati M., Kazemi A., Kheirabadi G., Ebrahimi A., Bahrami M. 2017. Postpartum depression risk factors: A narrative review. J Educ Health Promot. 6:60. doi: 10.4103/jehp.jehp_9_16. PMID: 28852652; PMCID: PMC5561681.
20. Goeser A.L., 2008. Postpartum depression. US Pharm. 2008; 33(11):16-20.
Guille C, Newman R, Fryml LD, Lifton CK, Epperson CN. 2013. Management of postpartum depression. J Midwifery Womens Health. 58(6):643-53. doi: 10.1111/jmwh.12104. Epub 2013 Oct 16. PMID: 24131708; PMCID: PMC4101986.
21. Hauser, J. 2016. Risks of Electroconvulsive Therapy
Ito S, Lee A. 2003. Drug excretion into breast milk--overview. Adv Drug Deliv Rev. 55(5):617-27. doi: 10.1016/s0169-409x(03)00034-6. PMID: 12706545.
22. Ivorra, J. L., Sanjuan, J., Jover, M., Carot, J. M., Frutos, R., & Molto, M. D. 2010. Gene environment interaction of child temperament. Journal of Developmental and Behavioral Pediatrics, 31(7), 545e554. https://doi.org/10.1097/DBP.0b013e3181ee4072.
23. Koutra K, Vassilaki M, Georgiou V, Koutis A, Bitsios P, Kogevinas M, Chatzi L. 2018. Pregnancy, perinatal and postpartum complications as determinants of postpartum depression: the Rhea mother-child cohort in Crete, Greece. Epidemiol Psychiatr Sci. (3):244-255. doi: 10.1017/S2045796016001062. Epub 2016 Dec 22. PMID: 28004625; PMCID: PMC6998861.
24. Lanza di Scalea T, Wisner KL. Antidepressant medication use during breastfeeding. Clin Obstet Gynecol. 2009. Sep;52(3):483-97. doi: 10.1097/GRF.0b013e3181b52bd6. PMID: 19661763; PMCID: PMC2902256.
25. Larsen ER, Damkier P, Pedersen LH, Fenger-Gron J, Mikkelsen RL, Nielsen RE, Linde VJ, Knudsen HE, Skaarup L, Videbech P. 2015. Danish Psychiatric Society; Danish Society of Obstetrics and Gynecology; Danish Paediatric Society; Danish Society of Clinical Pharmacology. Use of psychotropic drugs during pregnancy and breast-feeding. Acta Psychiatr Scand Suppl.;(445):1-28. doi: 10.1111/acps.12479. PMID: 26344706.
26. Malhi, G.S., Tanious, M., Das, P. et al. 2013. Potential Mechanisms of Action of Lithium in Bipolar Disorder. CNS Drugs 27, 135–153.
27.Masters, G. A., Brenckle, L., Sankaran, P., Person, S. D., Allison, J., Moore Simas, T. A.,Byatt, N. 2019. Positive screening rates for bipolar disorder in pregnant and postpartum women and associated risk factors. General Hospital Psychiatry. doi:10.1016/j.genhosppsych.2019.0
28. Miller, L., & LaRusso, E. 2011. Preventing Postpartum Depression. Psychiatric Clinics Of North America, 34(1), 53-65. http://dx.doi.org/10.1016/j.psc.2010.11.010
29. Moses-Kolko, E. L., Berga, S. L., Kalro, B., Sit, D. K. Y., & Wisner, K. L. 2009. Transdermal estradiol for postpartum depression: A promising treatment option. Clinical Obstetrics and Gynecology, 52(3), 516–529.
30. Muraca, G. M., & Joseph, K. S. 2014. The Association Between Maternal Age and Depression. Journal of Obstetrics and Gynaecology Canada, 36(9), 803–810. doi:10.1016/s1701-2163(15)30482-5
31. Naoi M, Maruyama W, Shamoto-Nagai M. 2018. Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis. J Neural Transm (Vienna). 125(1):53-66. doi: 10.1007/s00702-017-1709-8. Epub 2017 Mar 14. PMID: 28293733.
32. O'Hara MW, Engeldinger J. 2018. Treatment of Postpartum Depression: Recommendations for the Clinician. Clin Obstet Gynecol. 61(3):604-614. doi: 10.1097/GRF.0000000000000353. PMID: 29351116.
33. Orsolini L, Bellantuono C. 2015. Serotonin reuptake inhibitors and breastfeeding: a systematic review. Human Psychopharmacology (1):4-20. doi: 10.1002/hup.2451. PMID: 25572308.
34. Payne, J. L. 2020. Genetic basis for postpartum depression. Biomarkers of Postpartum Psychiatric Disorders, 15–34. doi:10.1016/b978-0-12-815508-0.00002-3
35. Pearlstein, T., Howard, M., Salisbury, A., & Zlotnick, C. 2009. Postpartum depression. American Journal of Obstetrics and Gynecology, 200(4), 357–364. doi:10.1016/j.ajog.2008.11.033
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Aleksandra Sadowska, Aleksandra Welkier, Adam Sobiński, Paula Kwaśniewska, Patrycja Śliwa-Tytko, Joanna Miśkiewicz, Aleksandra Dudek, Patrycja Pietrusińska, Jakub Moder, Anna Dziewierz

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 87
Number of citations: 0